top of page
ARVO 2026: DURABLE RETINA THERAPEUTICS SHOWCASE
Moderators: Robert L. Avery, MD and Lejla Vajzovic, MD
Panel: Michael Goldstein, MD and Garrett Hamontree
Room: 403
Start | Company | Presenter |
|---|---|---|
1:00 PM | Introduction | Julie Schallhorn, MD, MS |
1:02 PM | Cavalry Biosciences | Preston Klassen, MD, MHS, CEO |
1:07 PM | Claris Biotherapeutics, Inc. | Stephen Brady, President & CEO |
1:12 PM | Discussion | |
1:19 PM | Oculis Holding AG | Riad Sherif, MD, CEO |
1:24 PM | OKYO Pharma | Robert J. Dempsey, CEO |
1:29 PM | EyeDura Therapeutics | Srini Venkatesh, PhD, CEO |
1:34 PM | Discussion | |
1:42 PM | TECLens | Madhu Ayyagari, PhD, MBA, CEO |
1:47 PM | iVeena | Bali Ambati, MD, PhD, MBA, Founder & Chief Medical Officer |
1:52 PM | Lento Bio, Inc. | Kris Barnes, PhD, CEO |
1:57 PM | Discussion | |
2:05 PM | ForSight VISION6 | Vance Thompson, MD |
2:10 PM | Drop Mate, Inc | Vikram Shankar, MD, MPH, Co-founder & CEO |
2:15 PM | Theialife | Tom Ruggia, President & CEO |
2:20 PM | Discussion | |
2:28 PM | Conclusion | Kendall Donaldson, MD, MS |
2:30 PM | End of Session |
Anchor 1
bottom of page